Clinical Trials List
Protocol NumberCQAB149B2346
2008-03-30 - 2008-12-31
Phase III
Terminated2
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 簡志峰 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Principal Investigator
Co-Principal Investigator
- Liang-wen Hang 無
- 邱國樑 無
- Te-Chun Hsia 無
- 陳鴻仁 無
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
290 participants
